. Author manuscript; available in PMC: 2020 Aug 1.

Published in final edited form as: Gynecol Oncol. 2019 Jun 18;154(2):328–332. doi: 10.1016/j.ygyno.2019.06.001

Table 2:

Location of recurrence and mixed or pure clear cell carcinoma CCC) by treatment group

Characteristic	Observation	Chemo^* Alone	Chemo + Radiation	Radiation	Brachytherapy	p-value

	N (%)	N (%)	N (%)	N (%)	N (%)
Histology						0.042
Mixed	10 (37)	5 (56)	22 (76)	12 (71)	19 (63)
Pure CCC	17 (63)	4 (44)	7 (24)	5 (29)	11 (37)
Recurrence location						0.911
Pelvic	1 (14)	1 (20)	1 (11)	3 (33)	3 (43)
Nodal	2 (29)	1 (20)	3 (33)	1 (11)	1 (14)
Distant	4 (57)	3 (60)	5 (56)	5 (56)	3 (43)

Chemo= Chemotherapy; Mixed histology group was more likely to received adjuvant treatment compared to the pure UCCC group. Pelvic recurrence locations were not related to type of treatment received.